Flavoxate Hydrochloride

Specifications

3717-88-2CAS Number

223-066-4EC Number

2-piperidin-1-ylethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate;hydrochlorideIUPAC Name

C24H26ClNO4Chemical Formula

427.9 g/molMolecular Weight

Flavoxate hydrochloride; 3717-88-2; Flavoxate HCL; Urispas; Spasmal; DW-61; NSC-114649; DTXSID1047784; 9C05J6089W; 2-Piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate hydrochloride; CHEBI:5089; DTXCID1027764; NSC114649; 4H-1-Benzopyran-8-carboxylic acid, 3-methyl-4-oxo-2-phenyl-, 2-(1-piperidinyl)ethyl ester, hydrochloride; Urispas 200; Hydrochloride, Flavoxate; RefChem:56749; DW 61; 2-(Piperidin-1-yl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate monohydrochloride; 223-066-4; Bladderon; Peflate; Flavoxate (hydrochloride); DW 61 (flavoxate); 2-(piperidin-1-yl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate hydrochloride; Rec 7/0040; Rec-7-0040;DW61; MFCD00072099; C24H26ClNO4; Piperidinoethyl-3-methylflavone-8-carboxylate hydrochloride; Spasuret hydrochloride; Genurin; Spasuret; Urispadol; Verrispasmin amp.; AK 123; NCGC00016636-01; CAS-3717-88-2; CCRIS 1950; SR-01000872667; UNII-9C05J6089W; Prestwick_884; EINECS 223-066-4; NSC 114649; REC 7-0040; Flavoxate hydrochloride [USAN:USP:JAN]; Flavoxate hydrochloride CRS; 2-piperidin-1-ylethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate hydrochloride; MLS002154247; SCHEMBL124540; HY-B0549AR; orb1310369; CHEMBL1200875; SCHEMBL29395220; HY-B0549A; MSK11330A; XOEVKNFZUQEERE-UHFFFAOYSA-N; 1-Piperidinoethanol, hydrochloride; GLXC-06519; HMS1568B06; Flavoxate HCl - Bio-X trade mark; FLAVOXATE HYDROCHLORIDE [MI]; Tox21_110537; EBC-12087; Flavoxate (hydrochloride) (Standard); Flavoxate hydrochloride (JP18/USP); FLAVOXATE HYDROCHLORIDE [JAN]; s4027; FLAVOXATE HYDROCHLORIDE [USAN]; AKOS025310107; Tox21_110537_1; AC-1093; CCG-220242; FF23299; FLAVOXATE HYDROCHLORIDE [MART.]; 1-Piperidineethanol, 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate, hydrochloride; FLAVOXATE HYDROCHLORIDE [USP-RS]; FLAVOXATE HYDROCHLORIDE [WHO-DD]; NCGC00016636-05; 3-Methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylic acid 2-(1-piperidinyl)ethyl ester hydrochloride; 4H-1-Benzopyran-8-carboxylic acid, 3-methyl-4-oxo-2-phenyl-, 2-piperidinoethyl ester, hydrochloride; AS-12321; BF164464; SMR000499576; F0717; FLAVOXATE HYDROCHLORIDE [EP IMPURITY]; FLAVOXATE HYDROCHLORIDE [ORANGE BOOK]; NS00083275; SW197005-3; FLAVOXATE HYDROCHLORIDE [EP MONOGRAPH]; D00718; D90684; EN300-123535; FLAVOXATE HYDROCHLORIDE [USP MONOGRAPH]; Flavoxate hydrochloride, >=98% (HPLC), solid; F814885; SR-01000872667-1; Q27106648; WLN: T66 BO EVJ CR& D1 JVO2- AT6NTJ &GH; Z2768134941; 3-Methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylic acid hydrochloride; 4H-1-Benzopyran-8-carboxylic acid, 2-piperidinoethyl ester, hydrochloride; Flavoxate hydrochloride, European Pharmacopoeia (EP) Reference Standard; Flavoxate hydrochloride, United States Pharmacopeia (USP) Reference Standard; 1-(2-{[(3-methyl-4-oxo-2-phenyl-4H-chromen-8-yl)carbonyl]oxy}ethyl)piperidinium chloride; 2-(1-piperidyl)ethyl 3-methyl-4-oxo-2-phenyl-chromene-8-carboxylate;hydrochloride; 2-(piperidin-1-yl)ethyl3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylatehydrochloride; 2-Piperidinoethyl-3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate hydrochloride; 4H-1-Benzopyran-8-carboxylic acid, 2-(1-piperidinyl)ethyl ester, hydrochloride; 2-(Piperidin-1-yl)ethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate--hydrogen chloride (1/1)Synonyms